Guggenheim Securities



Guggenheim Securities Recent News

Fortinet Must Face 'Reality Of Constrained Demand' After Mixed Q3, Analyst Says
Meta Platforms Reports Solid Q3 Print, But Q4 Outlook Is A Concern: 7 Analysts Dive Deeper Into Results
Is Splunk A Good Investment After Cisco Deal Announcement? 7 Analysts Weigh In
5 Lululemon Analysts Praise Apparel Maker's Q2 Print, Outlook: 'Momentum Across The Board'
Palo Alto Networks Stock Shoots Up After Q4 Print: 5 Analysts Deep Dive Into Why, Outlook
Oracle Exhibits Strong And Sustained Cloud Momentum: 5 Wall Street Analysts React To FQ4 Results
Will CrowdStrike Have A Weak Q2? 4 Analysts On 'Solid' Q1 Print, Macro Pressures
Chewy Inc's Shares Surge As Q1 Earnings Exceed Expectations: 4 Analysts Applaud Results
Rain Oncology's Phase 3 Data Casts Doubt On Other Trials: Analyst Reevaluate Their Views
7 Lululemon Athletica Analysts On Q4 Print: 'Demand For LULU's Merchandise Remains Healthy And Strong,' But There May Be A Headwind
7 CrowdStrike Holdings Analysts Dissect The 'Solid' Beat And Raise Quarter
Why 5 Target Analysts Are Maintaining Ratings Following Q4 Results
These 6 Palo Alto Networks Analysts Are Happy With FQ2 Print
Why These 4 Pinterest Analysts Are Happy With Q4 Results
Tesla's Pricing Power Will Suffer Due To New IRS Rules For EV Sales Credit, Analyst Says
Oracle Faces Uncertain Macro Outlook In 2023, 3 Analysts' Takeaways On FQ2 Print
Beauty Is Pain To The Pocketbook: Ulta Posts Q3 Earnings Beat, Raises Prices And Outlook
8 Zscaler Analysts Offer Their Takes On Q3 Print: Why The Company May 'Need To Tread Carefully Throughout FY23'
Why These 3 Foot Locker Analysts Are More Excited About New CEO Than Q2 Results
Square's Recent Weakness Is An Investor's Chance To Buy Stock, Says Analyst
Amneal Analyst: Pharma Well-Positioned Ahead Of 2021 Generic Launches
Bristol-Myers Squibb Analyst Sees Multiple Expansion Story, Limited Near-Term Downside Risk
Arvinas TPD Therapies Have Great Potential, Guggenheim Says In Bullish Initiation